ID   GREM1_RAT               Reviewed;         184 AA.
AC   O35793;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   29-MAY-2024, entry version 131.
DE   RecName: Full=Gremlin-1;
DE   AltName: Full=Cysteine knot superfamily 1, BMP antagonist 1;
DE   AltName: Full=Down-regulated in Mos-transformed cells protein;
DE   Flags: Precursor;
GN   Name=Grem1; Synonyms=Cktsf1b1, Drm;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=9234736; DOI=10.1128/mcb.17.8.4801;
RA   Topol L.Z., Marx M., Laugier D., Bogdanova N.N., Boubnov N.V.,
RA   Clausen P.A., Calothy G., Blair D.G.;
RT   "Identification of drm, a novel gene whose expression is suppressed in
RT   transformed cells and which can inhibit growth of normal but not
RT   transformed cells in culture.";
RL   Mol. Cell. Biol. 17:4801-4810(1997).
RN   [2]
RP   INTERACTION WITH SLIT1 AND SLIT2, FUNCTION, AND MUTAGENESIS OF
RP   42-ASN--SER-44.
RX   PubMed=15528323; DOI=10.4049/jimmunol.173.10.5914;
RA   Chen B., Blair D.G., Plisov S., Vasiliev G., Perantoni A.O., Chen Q.,
RA   Athanasiou M., Wu J.Y., Oppenheim J.J., Yang D.;
RT   "Bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with
RT   Slits and act as negative regulators of monocyte chemotaxis.";
RL   J. Immunol. 173:5914-5917(2004).
CC   -!- FUNCTION: Cytokine that may play an important role during
CC       carcinogenesis and metanephric kidney organogenesis, as a BMP
CC       antagonist required for early limb outgrowth and patterning in
CC       maintaining the FGF4-SHH feedback loop. Down-regulates the BMP4
CC       signaling in a dose-dependent manner (By similarity). Antagonist of
CC       BMP2; inhibits BMP2-mediated differentiation of osteoblasts (in vitro)
CC       (By similarity). Acts as inhibitor of monocyte chemotaxis
CC       (PubMed:15528323). Can inhibit the growth or viability of normal cells
CC       but not transformed cells when is overexpressed.
CC       {ECO:0000250|UniProtKB:O60565, ECO:0000250|UniProtKB:O70326,
CC       ECO:0000269|PubMed:15528323, ECO:0000269|PubMed:9234736}.
CC   -!- SUBUNIT: Homodimer; can also form homooligomers. Interacts with BMP2;
CC       can form higher oligomers with BMP2 (By similarity). Interacts with
CC       SLIT1 and SLIT2 in a glycosylation-dependent manner (PubMed:15528323).
CC       {ECO:0000250|UniProtKB:O60565, ECO:0000269|PubMed:15528323}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the brain, kidney, spleen, and
CC       testis and weakly expressed in the lung and liver. Predominantly
CC       expressed in differentiated cells as neurons in brain, type I cells in
CC       lung and globlet cells in intestine. {ECO:0000269|PubMed:9234736}.
CC   -!- INDUCTION: Down-regulated in cells transformed by oncogenes.
CC       {ECO:0000269|PubMed:9234736}.
CC   -!- SIMILARITY: Belongs to the DAN family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y10019; CAA71126.1; -; mRNA.
DR   RefSeq; NP_062155.1; NM_019282.3.
DR   AlphaFoldDB; O35793; -.
DR   SMR; O35793; -.
DR   BioGRID; 248391; 1.
DR   IntAct; O35793; 1.
DR   STRING; 10116.ENSRNOP00000035888; -.
DR   GlyCosmos; O35793; 2 sites, No reported glycans.
DR   GlyGen; O35793; 2 sites.
DR   PhosphoSitePlus; O35793; -.
DR   PaxDb; 10116-ENSRNOP00000035888; -.
DR   Ensembl; ENSRNOT00000037895.4; ENSRNOP00000035888.2; ENSRNOG00000026053.4.
DR   Ensembl; ENSRNOT00000104302.1; ENSRNOP00000084612.1; ENSRNOG00000026053.4.
DR   Ensembl; ENSRNOT00055004073; ENSRNOP00055003077; ENSRNOG00055002564.
DR   Ensembl; ENSRNOT00055004076; ENSRNOP00055003080; ENSRNOG00055002564.
DR   Ensembl; ENSRNOT00060034725; ENSRNOP00060028516; ENSRNOG00060020085.
DR   Ensembl; ENSRNOT00060034741; ENSRNOP00060028528; ENSRNOG00060020085.
DR   Ensembl; ENSRNOT00065026125; ENSRNOP00065020543; ENSRNOG00065015738.
DR   Ensembl; ENSRNOT00065026131; ENSRNOP00065020549; ENSRNOG00065015738.
DR   GeneID; 50566; -.
DR   KEGG; rno:50566; -.
DR   UCSC; RGD:2359; rat.
DR   AGR; RGD:2359; -.
DR   CTD; 26585; -.
DR   RGD; 2359; Grem1.
DR   eggNOG; ENOG502QQ5X; Eukaryota.
DR   GeneTree; ENSGT00940000154209; -.
DR   HOGENOM; CLU_101024_0_0_1; -.
DR   InParanoid; O35793; -.
DR   OMA; TIHEDGC; -.
DR   OrthoDB; 5347549at2759; -.
DR   PhylomeDB; O35793; -.
DR   TreeFam; TF106445; -.
DR   PRO; PR:O35793; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000026053; Expressed in colon and 12 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0036122; F:BMP binding; ISS:UniProtKB.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0048018; F:receptor ligand activity; ISO:RGD.
DR   GO; GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; ISO:RGD.
DR   GO; GO:0043184; F:vascular endothelial growth factor receptor 2 binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0009887; P:animal organ morphogenesis; ISO:RGD.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; ISO:RGD.
DR   GO; GO:0060379; P:cardiac muscle cell myoblast differentiation; ISO:RGD.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0007267; P:cell-cell signaling; ISO:RGD.
DR   GO; GO:0030199; P:collagen fibril organization; ISO:RGD.
DR   GO; GO:0048263; P:determination of dorsal identity; ISO:RGD.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; ISO:RGD.
DR   GO; GO:0043542; P:endothelial cell migration; ISO:RGD.
DR   GO; GO:0060173; P:limb development; ISO:RGD.
DR   GO; GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030502; P:negative regulation of bone mineralization; ISO:RGD.
DR   GO; GO:1900158; P:negative regulation of bone mineralization involved in bone maturation; ISO:RGD.
DR   GO; GO:0046851; P:negative regulation of bone remodeling; ISO:RGD.
DR   GO; GO:1900155; P:negative regulation of bone trabecula formation; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:RGD.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0002689; P:negative regulation of leukocyte chemotaxis; IDA:RGD.
DR   GO; GO:0090027; P:negative regulation of monocyte chemotaxis; IDA:BHF-UCL.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IMP:ARUK-UCL.
DR   GO; GO:0033689; P:negative regulation of osteoblast proliferation; ISO:RGD.
DR   GO; GO:0090291; P:negative regulation of osteoclast proliferation; ISO:RGD.
DR   GO; GO:0060392; P:negative regulation of SMAD protein signal transduction; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:1900086; P:positive regulation of peptidyl-tyrosine autophosphorylation; ISO:RGD.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0009954; P:proximal/distal pattern formation; ISO:RGD.
DR   GO; GO:0010717; P:regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0051893; P:regulation of focal adhesion assembly; ISO:RGD.
DR   GO; GO:0038098; P:sequestering of BMP from receptor via BMP binding; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0060676; P:ureteric bud formation; ISO:RGD.
DR   Gene3D; 2.10.90.10; Cystine-knot cytokines; 1.
DR   InterPro; IPR006207; Cys_knot_C.
DR   InterPro; IPR029034; Cystine-knot_cytokine.
DR   InterPro; IPR004133; DAN.
DR   InterPro; IPR017159; Gremlin-1/2.
DR   PANTHER; PTHR15283; GREMLIN 1; 1.
DR   PANTHER; PTHR15283:SF3; GREMLIN-1; 1.
DR   Pfam; PF03045; DAN; 1.
DR   PIRSF; PIRSF037254; Gremlin_precursor; 1.
DR   SMART; SM00041; CT; 1.
PE   1: Evidence at protein level;
KW   Cytokine; Disulfide bond; Glycoprotein; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000250"
FT   CHAIN           25..184
FT                   /note="Gremlin-1"
FT                   /id="PRO_0000006717"
FT   DOMAIN          94..184
FT                   /note="CTCK"
FT   REGION          24..78
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        40..56
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        2
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        42
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        94..144
FT                   /evidence="ECO:0000250|UniProtKB:O60565"
FT   DISULFID        108..158
FT                   /evidence="ECO:0000250|UniProtKB:O60565"
FT   DISULFID        118..176
FT                   /evidence="ECO:0000250|UniProtKB:O60565"
FT   DISULFID        122..178
FT                   /evidence="ECO:0000250|UniProtKB:O60565"
FT   MUTAGEN         42..44
FT                   /note="NDS->IEA: No interaction with SLIT1."
FT                   /evidence="ECO:0000269|PubMed:15528323"
SQ   SEQUENCE   184 AA;  20680 MW;  90AC99749B1AD8F6 CRC64;
     MNRTAYTVGA LLLLLGTLLP AAEGKKKGSQ GAIPPPDKAQ HNDSEQTQSP PQPGSRTRGR
     GQGRGTAMPG EEVLESSQEA LHVTERKYLK RDWCKTQPLK QTIHEEGCNS RTIINRFCYG
     QCNSFYIPRH IRKEEGSFQS CSFCKPKKFT TMMVTLNCPE LQPPTKKKRV TRVKQCRCIS
     IDLD
//
